Elephas Biosciences Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Elephas Biosciences Corporation - overview
Established
2020
Location
Madison, WI, US
Primary Industry
Biotechnology
About
Based in Wisconsin, US, and founded in 2020 by its CEO Maneesh Arora, Elephas Biosciences Corporation operates as a developer and provider of biotechnology imaging platforms to help in diagnostics and novel pharmaceutical therapies. In November 2025, Elephas Biosciences Corp raised USD 40 million in series B funding from Northpond Ventures, ARCH Venture Partners, State of Wisconsin Investment Board, Tao Capital Partners, Sands Capital Alternatives, and Venture Investors. Elephas Biosciences Corp. offers an oncology diagnostics platform that utilizes live fragments from a patient biopsy and treats those fragments with potential therapies and combinations.
The company's CybridTM platform incorporates a comprehensive suite of assays to help understand the mechanisms of action of immunotherapeutic compounds indicating drug response, and it also provides insights into cancer treatment decisions and accelerates immuno-oncology drug development. The organization plans to use the November 2025 funding to launch and commercialize its Elephas Live platform as a laboratory-developed test that predicts immunotherapy response using live tumor biopsies.
Current Investors
ARCH Venture Partners, Tao Capital Partners, Sands Capital Alternatives
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories, Healthcare IT, Oncology/Cancer Treatment, Diagnostic Equipment, Pharmaceutical Research & Development
Website
www.elephas.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.